
Edelweiss Alternative Research showed that insiders from select banks, FMCG, chemical, pharma and real estate sold some of their shares in July

Aurobindo Pharma on August 12 posted a 1.68% decline in its consolidated net profit to Rs 769.97 crore for the quarter ended on June 30.
Mudit Goyal of SMC Global said till the time largecaps will continue its upward run, we can expect to see further higher levels.

Market news: Sensex jumped 237 points or 0.43% surpassing the 56,000-mark at 56,029. Nifty50 advanced 69 points or 0.42%.
Most sectoral indices on the NSE closed in the red. IT and FMCG stocks led the rally, while metals, banks and financials were under pressure.

BSE Sensex surged 209.69 points or 0.38% towards the fag-end of the trading session to settle at record 55,792.27

Data showed that 10 Nifty companies logged more than 100% growth in net profit in Q1FY22, while eight companies turned around

In early deals, Sensex dropped 150 points or 0.27% to 55,431. NSE Nifty 50 was at 16,545, down 17 points or 0.11%.

Lupin has received tentative approval from the USFDA for its Abbreviated New Drug Application (ANDA) Brivaracetam Tablets

Foreign portfolio investors (FPIs) sold shares worth Rs 1,088.32 crore, while DIIs were net buyers to the tune of of Rs 506.21 crore on August 16.